JDS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Interpretive Summary
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McDougall, S.
Right arrow Articles by Anniss, F. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McDougall, S.
Right arrow Articles by Anniss, F. M.
J. Dairy Sci. 87:2967-2976
© American Dairy Science Association, 2004.

Production and Health of Pasture-Fed Dairy Cattle Following Oral Treatment with the Ionophore Lasalocid

S. McDougall, L. Young and F. M. Anniss

Animal Health Centre, Morrinsville, New Zealand

Corresponding author: S McDougall; e-mail: smcdoug{at}ahc.co.nz.

The aim of the study was to evaluate the effect of feeding the ionophore lasalocid on the productivity and health of seasonally calving, pasture-fed dairy cows. Dairy cows (n = 1020) from 4 herds were enrolled in a split-herd, prospective intervention study. Cows were blocked by breed and age, ranked on previous production, and then assigned to 2 treatment groups. Treatment cows were each exposed to 300 to 350 mg of lasalocid/d commencing 3 wk before and ending 18 wk after the start of the seasonal calving period. Milk production was determined on 3 occasions for each cow at approximately monthly intervals (herd tests 1 to 3), body condition score was determined fortnightly, and all disease occurrences were recorded. Lasalocid treatment increased milk volume milk protein and milk fat production by ~2%, without altering milk composition. Fewer lasalocid-treated cows than control cows (7.3 vs. 11.6%, respectively) were diagnosed with clinical mastitis. Lasalocid treatment of pasture-fed dairy cows resulted in reduced mastitis incidence and increased milk production without changes in body condition or negative effects on metabolic processes as monitored by metabolite concentrations.

Key Words: lasalocid • dairy cow • disease • milk production

Abbreviation key: BUN = blood urea nitrogen, MS = milk solids, NDE = not detected in estrus, SDE = standard error of the difference




This article has been cited by other articles:


Home page
J DAIRY SCIHome page
T. F. Duffield, A. R. Rabiee, and I. J. Lean
A Meta-Analysis of the Impact of Monensin in Lactating Dairy Cattle. Part 3. Health and Reproduction
J Dairy Sci, June 1, 2008; 91(6): 2328 - 2341.
[Abstract] [Full Text] [PDF]


Home page
J DAIRY SCIHome page
R. Martineau, C. Benchaar, H. V. Petit, H. Lapierre, D. R. Ouellet, D. Pellerin, and R. Berthiaume
Effects of Lasalocid or Monensin Supplementation on Digestion, Ruminal Fermentation, Blood Metabolites, and Milk Production of Lactating Dairy Cows
J Dairy Sci, December 1, 2007; 90(12): 5714 - 5725.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Dairy Science Association ®.